Drugs Approved for Soft Tissue Sarcoma
- Afamitresgene Autoleucel
- Atezolizumab
- Atezolizumab and Hyaluronidase-tqjs
- Cosmegen (Dactinomycin)
- Dactinomycin
- Doxorubicin Hydrochloride
- Eribulin Mesylate
- Fyarro (Sirolimus Protein-Bound Particles)
- Gleevec (Imatinib Mesylate)
- Halaven (Eribulin Mesylate)
- Imatinib Mesylate
- Pazopanib Hydrochloride
- Sirolimus Protein-Bound Particles
- Tazemetostat Hydrobromide
- Tazverik (Tazemetostat Hydrobromide)
- Tecelra (Afamitresgene Autoleucel)
- Tecentriq (Atezolizumab)
- Tecentriq Hybreza (Atezolizumab and Hyaluronidase-tqjs)
- Trabectedin
- Votrient (Pazopanib Hydrochloride)
- Yondelis (Trabectedin)
Drug Combinations Used in Soft Tissue Sarcoma